Low-dose decitabine combined with camrelizumab for refractory/relapsed mycosis fungoides/Sézary syndrome: a retrospective exploratory study

Shan Meng, Longfei Zhu, Bin Peng, Chen Tu, Yilin Zhang, Xingmei Cao, Liufang Gu

Open source

DOI: 10.3389/fonc.2026.1851475
Published: 2026-08-06
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1851475,
  title = {Low-dose decitabine combined with camrelizumab for refractory/relapsed mycosis fungoides/Sézary syndrome: a retrospective exploratory study},
  author = {Shan Meng and Longfei Zhu and Bin Peng and Chen Tu and Yilin Zhang and Xingmei Cao and Liufang Gu},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1851475},
  url = {https://doi.org/10.3389/fonc.2026.1851475}
}

RIS

TY  - JOUR
TI  - Low-dose decitabine combined with camrelizumab for refractory/relapsed mycosis fungoides/Sézary syndrome: a retrospective exploratory study
AU  - Shan Meng
AU  - Longfei Zhu
AU  - Bin Peng
AU  - Chen Tu
AU  - Yilin Zhang
AU  - Xingmei Cao
AU  - Liufang Gu
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1851475
UR  - https://doi.org/10.3389/fonc.2026.1851475
ER  -

APA

Meng, S., Zhu, L., Peng, B., Tu, C., Zhang, Y., Cao, X., & Gu, L. (2026). Low-dose decitabine combined with camrelizumab for refractory/relapsed mycosis fungoides/Sézary syndrome: a retrospective exploratory study. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1851475

Source records

crossref · retrieved 2026-09-25T01:26:42.713Z